Aging isn't uniform. Your heart might age faster than your brain, predisposing you to cardiovascular disease over Alzheimer's. Quantifying these organ-specific aging rates offers a more precise diagnostic tool than a single 'biological age' and explains why people succumb to different age-related illnesses.

The distinction between "diseases of late life" and aging itself is artificial. Conditions like Alzheimer's or most cancers are simply aspects of aging that have been given disease-like names. This unifies them as targets for a single, comprehensive anti-aging medical intervention.

While PET scans show lower glucose uptake in Alzheimer's brains, this may not be due to insulin resistance ("type 3 diabetes"). Studies show these brains can absorb glucose normally when cognitively stimulated. This suggests the issue is a lack of demand from inactive brain regions, not a failed supply mechanism.

Alzheimer's can be understood as a vascular disease rooted in nitric oxide deficiency. This decline impairs blood flow, glucose uptake, and inflammation regulation in the brain. Therefore, strategies to restore nitric oxide address the physiological root causes of the disease, not just the symptoms like plaque buildup.

Alzheimer's is a disease of midlife. Pathological changes in the brain start to occur from around age 30, but the first noticeable cognitive symptoms typically don't manifest until one's late 60s or 70s. This highlights a crucial, multi-decade window for prevention and intervention.

Despite common belief, only about 3-5% of Alzheimer's cases are driven by inherited genetic mutations. The vast majority are linked to lifestyle factors like diet, exercise, and sleep, making it a largely preventable disease if proactive measures are taken early in life.

Major age-related illnesses like cancer, heart disease, and dementia share a common root cause: the biological process of aging. Slowing the decline of aging would be a more effective strategy for preventing these diseases than tackling each one individually, leading to more healthy years of life.

Amyloid beta, often demonized as a toxic waste product in Alzheimer's, is fundamentally an antimicrobial peptide that protects brain cells. The problem arises not from its existence, but from the brain's inability to clear it effectively during sleep, leading to harmful accumulation.

The next frontier in aging diagnostics is measuring the age of individual cell types from blood proteins. The biological age of specific cells, like astrocytes or muscle cells, is a much stronger predictor for diseases like Alzheimer's and ALS than the age of the whole organ.